Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Apr 10, 2022
Date Accepted: Oct 11, 2022

The final, peer-reviewed published version of this preprint can be found here:

The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study

Xiao T, Wang C, Yang M, Yu T, Shen L, Xu X, Yang J, Ou CQ, Xing H

The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study

JMIR Public Health Surveill 2022;8(12):e38628

DOI: 10.2196/38628

PMID: 36480259

PMCID: 9782330

Risk factors for cervical cytological abnormalities among women infected with non-16/18 high-risk human papillomavirus: a cross-sectional study

  • Ting Xiao; 
  • Chunhua Wang; 
  • Mei Yang; 
  • Tingyu Yu; 
  • Liang Shen; 
  • Xiaohan Xu; 
  • Jun Yang; 
  • Chun-Quan Ou; 
  • Hui Xing

ABSTRACT

Objective:

The increasing prevalence of non-16/18 high-risk human papillomavirus (hrHPV) infection has recently drawn much attention. Abnormal cytological findings in non-16/18 hrHPV infected women may progress to cervical cancer. We aimed to identify the risk factors for cervical cytological abnormalities among women infected with non-16/18 hrHPV.

Methods:

A total of 314,587 women had been recruited for cervical cancer screening in Xiangyang city of China from January 2017 to February 2018. Of them, 311,604 women were analyzed for HPV genotyping and 17,523 non-16/18 hrHPV-positive women were further analyzed for cytology. A logistic regression model was conducted to assess risk factors for cytological abnormalities among these non-16/18 hrHPV infected women.

Results:

The non-16/18 hrHPV infection rate was 5.88% (18,323/311,604), three-fold as the infection rate of hrHPV 16/18 (1.95%, 6,068/311,604). In non-16/18 hrHPV infected women, the prevalence rates of overall cervical cytological abnormalities and high-grade cytological abnormalities were 13.46% and 1.17%. Multivariate logistic regression analysis revealed that women received middle or high school education were at a higher risk of cytological abnormalities than primary education (OR=1.31, 95%CI: 1.17-1.45; OR=1.32, 95%CI: 1.14-1.53). Living in rural areas (OR=2.58, 95%CI: 2.29-2.90), gravidity>=3 (OR=2.77, 95%CI: 1.19-6.45), cervical abnormalities detected on pelvic examination (OR=1.22, 95%CI: 1.11-1.34), and accepting cervical cancer screening over 3 years (OR=0.79, 95%CI: 0.62-1.00) were associated with cytological abnormalities. The risk factors for high-grade cytological abnormalities included middle education (OR=1.45, 95%CI: 1.07-1.98), living in rural regions (OR=1.52, 95%CI: 1.10-2.10) and abnormal cervix (OR=1.72, 95%CI: 1.30-2.26). Conclusion: The dominant epidemic of non-16/18 hrHPV infection is revealed and risk factors have been identified for cervical cytological abnormalities in Chinese women infected with non-16/18 hrHPV. These findings can provide important information for clinically actionable decisions for the implementation of cervical cancer screening program, early diagnosis, monitoring, and intervention.


 Citation

Please cite as:

Xiao T, Wang C, Yang M, Yu T, Shen L, Xu X, Yang J, Ou CQ, Xing H

The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study

JMIR Public Health Surveill 2022;8(12):e38628

DOI: 10.2196/38628

PMID: 36480259

PMCID: 9782330

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.